CollPlant Holdings Ltd., a regenerative medicine company, focuses on developing and commercializing tissue repair products for three-dimensional (3D) bio-printing of tissues and organs, dermal fillers for aesthetics, orthobiologics, and advanced wound care markets in the United States, Canada, and Europe. The company's products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. Its products include VergenixSTR, a soft tissue repair matrix intended for treatment of tendinopathy; VergenixFG, a wound-filling flowable gel for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; and BioInks for 3D printing of tissues and organs. CollPlant Holdings Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone972-73-232-5600
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$4.81 million
Profitability
Miscellaneous
Employees40
Next Earnings Date4/6/2020 (Estimated)
OptionableNot Optionable
COLLPLANT HOLDI/S (NASDAQ:CLGN) Frequently Asked Questions
What is COLLPLANT HOLDI/S's stock symbol?
COLLPLANT HOLDI/S trades on the NASDAQ under the ticker symbol "CLGN."
How were COLLPLANT HOLDI/S's earnings last quarter?
COLLPLANT HOLDI/S (NASDAQ:CLGN) issued its earnings results on Friday, November, 29th. The company reported ($0.41) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.26) by $0.15. The firm earned $0.68 million during the quarter, compared to the consensus estimate of $0.80 million. COLLPLANT HOLDI/S had a negative return on equity of 189.62% and a negative net margin of 94.57%. View COLLPLANT HOLDI/S's Earnings History.
When is COLLPLANT HOLDI/S's next earnings date?
What price target have analysts set for CLGN?
1 brokers have issued 1-year price objectives for COLLPLANT HOLDI/S's stock. Their forecasts range from $7.00 to $7.00. On average, they expect COLLPLANT HOLDI/S's stock price to reach $7.00 in the next twelve months. This suggests that the stock has a possible downside of 35.5%. View Analyst Price Targets for COLLPLANT HOLDI/S.
What is the consensus analysts' recommendation for COLLPLANT HOLDI/S?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for COLLPLANT HOLDI/S in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for COLLPLANT HOLDI/S.
Has COLLPLANT HOLDI/S been receiving favorable news coverage?
Media stories about CLGN stock have been trending extremely positive this week, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. COLLPLANT HOLDI/S earned a coverage optimism score of 5.0 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 6.0 out of 10, meaning that recent media coverage is somewhat likely to have an effect on the company's share price in the immediate future. View News Stories for COLLPLANT HOLDI/S.
Who are some of COLLPLANT HOLDI/S's key competitors?
What other stocks do shareholders of COLLPLANT HOLDI/S own?
Who are COLLPLANT HOLDI/S's key executives?
COLLPLANT HOLDI/S's management team includes the folowing people:
- Prof. Oded Shoseyov, Founder & Chief Scientist Officer (Age 63)
- Mr. Eran Rotem, Deputy CEO & CFO (Age 51)
- Dr. Philippe David Bensimon, VP of Regulation Affairs & Quality Assurance (Age 54)
- Dr. Nadav Orr, VP of R&D (Age 62)
- Mr. Yehiel Tal, Chief Exec. Officer (Age 67)
When did COLLPLANT HOLDI/S IPO?
(CLGN) raised $22 million in an IPO on Friday, December 9th 2016. The company issued 3,500,000 shares at a price of $6.23 per share. Ladenburg Thalmann served as the underwriter for the IPO and Roth Capital Partners was co-manager.
How do I buy shares of COLLPLANT HOLDI/S?
Shares of CLGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is COLLPLANT HOLDI/S's stock price today?
One share of CLGN stock can currently be purchased for approximately $10.85.
How big of a company is COLLPLANT HOLDI/S?
COLLPLANT HOLDI/S has a market capitalization of $41.45 million and generates $4.81 million in revenue each year. The company earns $-3,700,000.00 in net income (profit) each year or ($0.55) on an earnings per share basis. COLLPLANT HOLDI/S employs 40 workers across the globe.View Additional Information About COLLPLANT HOLDI/S.
What is COLLPLANT HOLDI/S's official website?
How can I contact COLLPLANT HOLDI/S?
COLLPLANT HOLDI/S's mailing address is 4 OPPENHEIMER ST. P.O.B 4132, REHOVOT L3, 7670104. The company can be reached via phone at 972-73-232-5600 or via email at [email protected]
MarketBeat Community Rating for COLLPLANT HOLDI/S (NASDAQ CLGN)
MarketBeat's community ratings are surveys of what our community members think about COLLPLANT HOLDI/S and other stocks. Vote "Outperform" if you believe CLGN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLGN will underperform the S&P 500 over the long term. You may vote once every thirty days.
